U.S. market Open. Closes in 3 hours 35 minutes

KOD | Kodiak Sciences Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 7.18 - 7.74
52 Week Range 2.1900 - 7.77
Beta 2.38
Implied Volatility 132.80%
IV Rank 47.85%
Day's Volume 272,419
Average Volume 281,280
Shares Outstanding 52,623,800
Market Cap 379,680,717
Sector Healthcare
Industry Biotechnology
IPO Date 2018-10-04
Valuation
Profitability
Growth
Health
P/E Ratio -1.78
Forward P/E Ratio N/A
EPS -4.05
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 111
Country USA
Website KOD
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as for the treatment of diabetic macular edema, naïve macular edema due to retinal vein occlusion, and non-proliferative diabetic retinopathy. The company's preclinical stage product candidate includes KSI-501, a bispecific conjugate to treat retinal diseases with an inflammatory component; and KSI-601, a triplet inhibitor for the treatment of dry AMD. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.
*Chart delayed
Analyzing fundamentals for KOD we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is weak. For more detailed analysis please see KOD Fundamentals page.

Watching at KOD technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on KOD Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙